Annual Report

Overview

The report describes the Group's 2021 ESG performance across its pharmaceutical and fitness businesses, with the reporting period covering 1 January to 31 December 2021. The Board is responsible for overseeing ESG policies, risks, objectives and disclosures, supported by the Executive Committee, management and a working group. The report highlights solar energy generation, energy-saving measures, approximately 225,928 tonnes of pharmaceutical-business water consumption and 258,917 tonnes in the fitness business. It also reports 1,180 employees within the ESG reporting scope and zero work-related fatalities during the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 January 2021 – 31 December 2021
Publication date: 30 March 2022
Language: English, Chinese
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services